By Teddy Cambosa The American Pharmacists Association (APhA) has shown readiness on the recent announcement by the Food and Drug Administration (FDA) in authorizing the use of the Moderna COVID-19 vaccine...

By NewsDesk  @bactiman63 Cambridge, MA  biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, Inc., announced Friday that the U.S. Food and Drug Administration’s...

In this news podcast, I look at the success and progress of the Pfizer and Moderna vaccines and their situation concerning receiving and Emergency Use Authorization (EUA). Today, the Centers for Disease...

By NewsDesk  @bactiman63 Massachusetts based biotechnology company, Moderna, announced today that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high...

By NewsDesk  @bactiman63 Cambridge, MA biotechnology company, Moderna, Inc. announced today that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273,...

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19)  induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques...

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody...

Clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, Inc.,  announced Monday positive interim clinical data of mRNA-1273, its vaccine candidate against...

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that...